Kendra Adams

Companies

• C4 Therapeutics (United States)Chief financial officer Sep 19, 2023 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• C4 Therapeutics (United States) CCCC382,323 shares²$1.1M at $2.88Sep 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 18, 2026Shares withheld for tax 2,775 shares at $3.39 of C4 Therapeutics (United States)²
• Sep 18, 2026Exercised options 6,250 shares of C4 Therapeutics (United States)²
• Feb 14, 2026Shares withheld for tax 15,381 shares at $1.89 of C4 Therapeutics (United States)³
• Feb 14, 2026Exercised options 30,950 shares of C4 Therapeutics (United States)³
• Feb 13, 2026Shares withheld for tax 1,863 shares at $1.89 of C4 Therapeutics (United States)³
• Feb 13, 2026Exercised options 3,750 shares of C4 Therapeutics (United States)³
• Feb 13, 2026Granted 240,000 shares of C4 Therapeutics (United States)³
• Sep 18, 2025Shares withheld for tax 2,775 shares at $3.32 of C4 Therapeutics (United States)⁴
• Sep 18, 2025Exercised options 6,250 shares of C4 Therapeutics (United States)⁴
• Feb 14, 2025Shares withheld for tax 4,559 shares at $3.18 of C4 Therapeutics (United States)⁵
• Feb 14, 2025Granted 87,100 shares of C4 Therapeutics (United States)⁵
• Feb 13, 2025Shares withheld for tax 1,863 shares at $3.20 of C4 Therapeutics (United States)⁵
• Nov 7, 2024Shares withheld for tax 1,102 shares at $6.04 of C4 Therapeutics (United States)⁶
• Nov 7, 2024Exercised options 3,750 shares of C4 Therapeutics (United States)⁶
• Sep 18, 2024Shares withheld for tax 1,837 shares at $6.38 of C4 Therapeutics (United States)⁷
• Sep 16, 2024Shares withheld for tax 661 shares at $6.36 of C4 Therapeutics (United States)⁸
• Sep 16, 2024Exercised options 2,250 shares of C4 Therapeutics (United States)⁸
• Feb 14, 2024Granted 36,700 shares of C4 Therapeutics (United States)⁹
• Feb 13, 2024Shares withheld for tax 1,301 shares at $6.53 of C4 Therapeutics (United States)⁹
• Sep 18, 2023Granted 25,000 shares of C4 Therapeutics (United States)¹⁰